Search research articles
Contact Us
Filters
Showing results (161-170 of 197) with videos related to
Page
of 20
Sort By:
Pathology International
|
June 26, 2007
Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells
Kenji Suzuki, Yusuke Kawauchi, Suresh S Palaniyandi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 8, 2021
Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohort
Masashi Kubota, Toru Kanno, Takahiro Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 22, 2020
Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan
Toru Kanno, Takahiro Inoue, Mutsushi Kawakita, et al.
Plos One
|
February 12, 2015
Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC)
Kiyoaki Tsukahara, Akira Kubota, Yasuhisa Hasegawa, et al.
Plos One
|
June 9, 2018
Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
Akira Kubota, Eiji Nakatani, Kiyoaki Tsukahara, et al.
Investigational New Drugs
|
February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma
Norimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Medical Oncology (Northwood, London, England)
|
June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study
Koji Nishimoto, Masato Karayama, Naoki Inui, et al.
Respiratory Medicine and Research
|
October 30, 2025
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial
Fumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, et al.
Journal of Cancer Research and Clinical Oncology
|
July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer
Yusuke Inoue, Naoki Inui, Masato Karayama, et al.
Oncology
|
July 19, 2014
Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan
Takanori Hama, Yutaka Tokumaru, Masato Fujii, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 197) with videos related to
Sort By:
Page
of 20
Pathology International
|
June 26, 2007
Blockade of interferon-gamma-inducible protein-10 attenuates chronic experimental colitis by blocking cellular trafficking and protecting intestinal epithelial cells
Kenji Suzuki, Yusuke Kawauchi, Suresh S Palaniyandi, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
March 8, 2021
Effect of optimal neoadjuvant chemotherapy on oncological outcomes of locally advanced bladder cancer with laparoscopic radical cystectomy: A matched-pair analysis in a multicenter cohort
Masashi Kubota, Toru Kanno, Takahiro Inoue, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
April 22, 2020
Perioperative and oncological outcomes of laparoscopic radical cystectomy with intracorporeal versus extracorporeal ileal conduit: A matched-pair comparison in a multicenter cohort in Japan
Toru Kanno, Takahiro Inoue, Mutsushi Kawakita, et al.
Plos One
|
February 12, 2015
Randomized phase III trial of adjuvant chemotherapy with S-1 after curative treatment in patients with squamous-cell carcinoma of the head and neck (ACTS-HNC)
Kiyoaki Tsukahara, Akira Kubota, Yasuhisa Hasegawa, et al.
Plos One
|
June 9, 2018
Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study
Akira Kubota, Eiji Nakatani, Kiyoaki Tsukahara, et al.
Investigational New Drugs
|
February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma
Norimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Medical Oncology (Northwood, London, England)
|
June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study
Koji Nishimoto, Masato Karayama, Naoki Inui, et al.
Respiratory Medicine and Research
|
October 30, 2025
Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting β2 adrenergic agonist: a randomized phase 2 screening trial
Fumiya Nihashi, Kazuki Furuhashi, Mitsuru Niwa, et al.
Journal of Cancer Research and Clinical Oncology
|
July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancer
Yusuke Inoue, Naoki Inui, Masato Karayama, et al.
Oncology
|
July 19, 2014
Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan
Takanori Hama, Yutaka Tokumaru, Masato Fujii, et al.
Page
of 20